Related Experiment Video
Updated: May 28, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Oncoantigens for an immune prevention of cancer
Abstract:
Vaccines are one of the main arms of preventive medicine. Recently a large series of experiments with cancer-prone genetically engineered mice have shown that preventive vaccines are also extremely efficacious inhibitors of the progression of carcinogenesis. Early vaccination affords significant and persistent protection, whereas its efficacy fades when neoplastic lesions become more advanced. Our current attempts to use combination strategies and technological advances to make vaccines effective in cancer prevention able to cure more advanced stages of cancer lesions are based on the temporary and systemic T(reg) removal, the preparation of new bimodular plasmids for DNA vaccination, and the search for fresh target oncoantigens.
Insights
Preventive vaccines show strong efficacy in inhibiting cancer progression in mice, particularly when administered early. However, their effectiveness diminishes with advanced neoplastic lesions, prompting research into new strategies for treating later cancer stages.
Area of Science:
- Immunology
- Oncology
- Preventive Medicine
- Cancer Research
Background:
- Vaccines are a cornerstone of preventive medicine.
- Recent studies demonstrate the efficacy of preventive vaccines in inhibiting carcinogenesis progression in genetically engineered mice.
- Early vaccination provides significant and lasting protection against cancer development.
Purpose of the Study:
- To investigate the potential of preventive vaccines in inhibiting cancer progression.
- To explore strategies for enhancing vaccine efficacy in treating more advanced cancer lesions.
- To identify novel oncoantigens for improved cancer prevention and treatment.
Main Methods:
- Experiments conducted on cancer-prone genetically engineered mice.
- Evaluation of early versus late vaccination timing on cancer progression.
- Development of combination strategies including temporary regulatory T cell (Treg) removal, bimodal DNA vaccination plasmids, and oncoantigen discovery.
Main Results:
- Early vaccination demonstrated significant and persistent inhibition of carcinogenesis.
- Vaccine efficacy decreased substantially when neoplastic lesions were more advanced.
- Current research focuses on combination strategies to overcome limitations in advanced cancer stages.
Conclusions:
- Preventive vaccines are highly effective in early stages of cancer development.
- Advanced neoplastic lesions present a challenge for current vaccine-based cancer prevention strategies.
- Novel approaches involving Treg modulation, advanced DNA vaccination, and new oncoantigen targets are crucial for treating advanced cancers.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Prevention
Some...
Cancer Prevention
Some...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
